Stock comparison

JNJvsVXUS

Johnson & Johnson vs Vanguard Total International Stock ETF. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

JNJ

Johnson & Johnson

$234.18

+16.15%

Pharmaceuticals$585.7BNYSE

VXUS

Vanguard Total International Stock ETF

$83.75

+11.34%

International — Developed$636.7BNASDAQ

60-day price, rebased to 100

JNJ +7.18% · VXUS +5.91%

Round-by-round

JNJ 2·VXUS 0· 4 ties

Tie

Valuation upside

-49.50% vs — to DCF fair value

Tie

Balance-sheet strength

Altman Z 5.48 vs —

EdgeJNJ

Fundamental quality

Piotroski 4.00 vs 0.00 (of 9)

Tie

Growth + margins

Rule-of-40 -5.70 vs —

EdgeJNJ

60-day momentum

+7.18% vs +5.91% price return

Tie

Market-cap liquidity

$585.7B vs $636.7B

Verdict

Across 6 categories, JNJ takes the edge with 2 wins to 0 (and 4 ties). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy on JNJ or VXUS

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.